Directors Robert Greene Sterne (moderator) and Michelle K. Holoubek will serve as discussion leaders for the Phoenix Issue VI session at the 2022 Virtual Leahy Institute of Advanced Patent Studies, hosted by The Naples Roundtable. Their session will occur on Friday, March 18, 2022 at 3:30 p.m. ET.

The Naples Roundtable explores ways to improve and strengthen the Patent System and accomplishes this mission by fostering an open dialogue among thought leaders, judges and academics on both sides of the “V.”


Does the patent system incentivize life science and artificial intelligence innovations? Do our systems adequately protect AI, diagnostics, therapeutics, and biologic drugs? The use of AI is pervasive in almost all areas of technology today but does our patent system support innovations of such technology or has the system becoming a stumbling block or an irrelevancy? The development of biologics is becoming a modern-day reality, not just a dream for the future, but is our patent system prepared? Are changes needed to the US Patent system to incentivize investment in the advanced diagnostics, therapeutics, and vaccines we will need for the next pandemic? Is a strong US patent system beneficial to global health? The “patent dance” for biologics has been controversial and shrouded in secrecy. But effective June 2, 2021, the information provided by the product sponsor will be available online in the FDA’s purple book. Are courts (Fed. Cir. in particular in Amgen v. Sanofi) defining antibody-based science in a way that is not similar to how scientists view it? How does the US compare to China?